Laticort (Hydrocortisone Butyrate)

Hydrocortisone butyrate binds to glucocorticoid receptors in skin cells, altering gene transcription to suppress pro‑inflammatory cytokines, inhibit leukocyte migration, and reduce vascular permeability, resulting in anti‑inflammatory and immunosuppressive effects.

The appropriate amount and frequency of Laticort are determined by the prescribing healthcare professional based on the specific condition, severity, patient age, and treatment area. Patients should follow the prescriber’s instructions exactly.

Safety in pregnancy and lactation has not been definitively established. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Laticort.

To request Laticort, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Hydrocortisone butyrate is a mid‑potency corticosteroid, offering stronger anti‑inflammatory action than low‑potency agents like hydrocortisone 1% but less potency than very strong steroids such as clobetasol propionate. Choice depends on disease severity, body area treated, and duration of therapy.

Store Laticort at room temperature, away from excess heat and moisture. Keep the tube or container tightly closed in its original packaging, and protect it from direct sunlight to maintain product stability.

Laticort is applied topically to the affected skin area in a thin layer, usually once or twice daily as directed by a healthcare professional. The skin should be clean and dry before application, and hands should be washed after use.

Serious risks include skin atrophy, telangiectasia, hypopigmentation, and systemic effects such as adrenal suppression when large areas are treated or used for prolonged periods. Patients should report any unusual skin changes or systemic symptoms to their doctor promptly.

Laticort should be avoided in individuals with known hypersensitivity to hydrocortisone butyrate or any formulation components, in patients with untreated fungal, bacterial, or viral skin infections, and in those where a less potent corticosteroid would be more appropriate.